CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Major Shareholder Sells $53,248.60 in Stock

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) major shareholder Stuart M. Sloan sold 532,486 shares of the company’s stock in a transaction on Wednesday, September 25th. The stock was sold at an average price of $0.10, for a total value of $53,248.60. Following the sale, the insider now owns 21,067,956 shares of the company’s stock, valued at approximately $2,106,795.60. The trade was a 2.47 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

CERo Therapeutics Price Performance

CERO stock opened at $0.25 on Thursday. The stock has a 50-day moving average price of $0.11 and a two-hundred day moving average price of $0.33. CERo Therapeutics Holdings, Inc. has a 12-month low of $0.06 and a 12-month high of $12.80.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.